Search





Results 1-10 of 10.
  • previous
  • 1
  • next
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC211802000Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model.SENEKOWITSCH-SCHMIDTKE R.; FISCHER K.; SCHUMACHER C.; BECKER I.; BECKER K.; APOSTOLIDIS Christos; NIKULA T.; SCHWAIGER M.
JRC211812000Cytotoxicity of the alpha Emitter 213-Bi Coupled to a Specific Antobody.MIEDERER M.; NIKULA T.; BRANDES K.; HANDSCHUH G.; ADAM C.; SCHUMACHER C.; APOSTOLIDIS Christos; BRECHBIEL M.; SCHMID E.; SENEKOWITSCH-SCHMIDTKE R.
JRC211822000Structure and Properties of Hydrated La(III), Nd(III) and Er(III) Methanesulonates.ARICO E.m.; ZINNER L.b.; KANELLAKOPOULOS Basil; DORNBERGER Ernst; REBIZANT Jean; APOSTOLIDIS Christos
JRC211852000Synthesis of a Novel Bifunctional Chelating Agent for Actinium Complexation.QUADI Ali; LOUSSOUARN A.; REMAUD P.; MORANDEAU L.; APOSTOLIDIS Christos; MUSIKAS C.; FAIVRE-CHAUVET A.; GESTIN J.-f.
JRC198252000Alpha-Emitting Bismuth Cyclohexybenzyl DTPA Constructs of Recombinant Humanized Anti-CD33 Antibodies: Pharmacokinetics, Bioactivity, Toxicity and Chemistry.NIKULA T.; MC DEVITT M.r.; WU Ch.; KOZAK R.w.; GARMESTANI K.; BRECHBIEL M.w.; CURCIO M.j.; PIPPIN C.g.; TIFFANI-JONES L.; GEERLINGS, SR. M.w.; APOSTOLIDIS Christos; MOLINET Roger; GEERLINGS, JR. M.w.
JRC198262000Validation of 213Bi-alpha Radioimmunotherapy for Multiple Myeloma.COUTURIER O.; FAIVRE-CHAUVET A.; FILIPPOVICH I.v.; THEDREZ Ph.; SAI-MAUREL C.; BARDIES M.; MISHRA A.k.; GAUVRIT M.; BLAIN G.; APOSTOLIDIS Christos; MOLINET Roger; ABBE J.-ch.; BATAILLE R.; WIJDENES John; CHATAL J-f.; CHEREL M.
JRC198232000High-Linear Energy Transfer (LET) alpha vs Low-LET beta Emitters in Radioimmunotherapy of Solid Tumors: Therapeutic Efficacy and Dose-Limiting Toxicity of 213Bi- vs 90Y-Labeled CO17-1A Fab' Fragments in a Human Colonic Cancer Model.BEHR T.m.; BEHE M.; STABIN M.g.; WEHRMANN E.; APOSTOLIDIS Christos; MOLINET Roger; STRUTZ F.; FAYYAZI A.; WIELAND E.; GRATZ S.t.; KOCH Lothar; GOLDENBERG D.m.; BECKER W.
JRC198242000Studies on the Red Marrow Dosimetry in Radioimmunotherapy. An Experimental Investigation of Factors Influencing the Radio-Induced Myelotoxicity in Therapy with beta-, Auger/Conversion Electron-, or alpha-Emitters.BEHR T.m.; SGOUROS G.; STABIN M.g.; BEHE M.; ANGERSTEIN Ch.; BLUMENTHAL R.d.; APOSTOLIDIS Christos; MOLINET Roger; SHARKEY R.m.; KOCH Lothar; GOLDENBERG D.m.; BECKER W.
JRC198222000Radiopeptide Therapy with Cholecystokinin-B/Gastrin Receptor Ligands: Dose-Limiting Toxicity and Therapeutic Efficacy of Auger / Conversion Electron (111-In, 140-Nd) vs alpha(213-Bi) or Conventional beta(90-Y, 153-Sm) Emitters.BEHR T.m.; BEBE M.; STABIN M.g.; ANGERSTEIN C.; MACH R.; HAGEMANN L.; APOSTOLIDIS Christos; MOLINET Roger; KOCH Lothar; ROESCH F.; BECKER W.
JRC198212000Binding of a Bi-213 Labeled Monoclonal Antibody Targeting a Tumor Specific Mutant E-Cadherin in Different Tumor Models.ADAM C.; SCHUHMACHER C.; BECKER K.; HANDSCHUH G.; NIKULA T.; APOSTOLIDIS Christos; FISCHER K.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.